Matching articles for "Lead poisoning"

Nonstandard Uses of Chelation Therapy

   
The Medical Letter on Drugs and Therapeutics • September 20, 2010;  (Issue 1347)
Chelation therapy involves oral administration, intravenous infusion or intramuscular injection of drugs that increase excretion of heavy metals. The Medical Letter’s last article on this subject found no...
Chelation therapy involves oral administration, intravenous infusion or intramuscular injection of drugs that increase excretion of heavy metals. The Medical Letter’s last article on this subject found no evidence that it was effective for treatment of cardiovascular disease. Since then, off-label use of chelation therapy has expanded to include treating children with autism and adults with Alzheimer’s disease, cancer and other chronic diseases.

Click here to view the free full article.
Med Lett Drugs Ther. 2010 Sep 20;52(1347):75-6 | Show Full IntroductionHide Full Introduction

Succimer - An Oral Drug for Lead Poisoning

   
The Medical Letter on Drugs and Therapeutics • August 9, 1991;  (Issue 850)
Succimer (meso 2,3-dimercaptosuccinic acid; DMSA; CHEMET - McNeil), a heavy metal chelator, was recently marketed in the USA for oral treatment of lead poisoning in ...
Succimer (meso 2,3-dimercaptosuccinic acid; DMSA; CHEMET - McNeil), a heavy metal chelator, was recently marketed in the USA for oral treatment of lead poisoning in children.
Med Lett Drugs Ther. 1991 Aug 9;33(850):78 | Show Full IntroductionHide Full Introduction